CN Patent

CN1832743A — 包含ag013736的剂型

Assigned to Pfizer Inc · Expires 2006-09-13 · 20y expired

What this patent protects

本发明提供了式(1)化合物或其可药用盐、溶剂合物或前药的剂型。本发明进一步提供了通过对哺乳动物使用这些剂型治疗细胞异常生长如癌症的方法。

USPTO Abstract

本发明提供了式(1)化合物或其可药用盐、溶剂合物或前药的剂型。本发明进一步提供了通过对哺乳动物使用这些剂型治疗细胞异常生长如癌症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN1832743A
Jurisdiction
CN
Classification
—
Expires
2006-09-13
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.